Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 131

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 8
Chunk 131
---
 be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over the period the warranty service is provided. Arrangements with Multiple Performance ObligationsWe also enter into arrangements which include multiple performance obligations. The most significant judgments related to these arrangements include:•Identifying the various performance obligations of these arrangements.•Estimating the relative standalone selling price of each performance obligation, typically using a directly observable method or calculated on a cost plus margin basis method.Revenue DisaggregatedThe following table represents our revenues disaggregated by product line (in thousands):Three months ended September 30,Nine months ended September 30,Product line2025202420252024Consumables$285,089 $264,875 $824,448 $770,730 Infusion Systems173,909 159,769 507,905 480,745 Vital Care77,992 164,487 358,205 500,766 Total Revenues$536,990 $589,131 $1,690,558 $1,752,241 The following table represents our revenues disaggregated by geography (in thousands):Three months ended September 30,Nine months ended September 30,Geography2025202420252024United States$307,131 $369,515 $1,030,808 $1,118,810 Europe, the Middle East and Africa115,092 101,710 309,839 295,409 APAC57,477 60,288 175,292 173,365 Other Foreign57,290 57,618 174,619 164,657 Total Revenues$536,990 $589,131 $1,690,558 $1,752,241     Contract Balances    The following table presents the changes in our contract balances for the nine months ended September 30, 2025 and 2024 (in thousands), which are included in accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets:

15

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

Contract LiabilitiesBeginning balance, January 1, 2025$39,403 Equipment revenue recognized(46,677)Equipment revenue deferred due to implementation51,563 Software revenue recognized(